Thyroid disorders in patients with polycystic ovarian syndrome in Benghazi
DOI:
https://doi.org/10.37376/benunivmedj.v2i2.7503Keywords:
PCOS,, thyroid, thyroiditis, hypothyroidism, hyperthyroidism, goiter, autoimmune, subclinical.Abstract
Abstract
Background: Recent studies have highlighted a higher occurrence of thyroid abnormalities in women diagnosed with polycystic ovary syndrome (PCOS), although the underlying mechanisms linking the two conditions remain uncertain.
Aim and Objectives: To determine the prevalence of thyroid dysfunction among patients with PCOS.
Methods: A retrospective review of medical records was conducted for 116 patients attending the endocrine clinic in Benghazi medical center during the period from the first of September to the end of October 2020.
Results: The mean age was (35.5±9.8 years), the mean body mass index for the study group was 31.8±6.5kg/m2. Among studied group; 81% of participants had oligomenorrhea, 97.4% had hirsutism, and 84% had ultrasound features of polycystic ovaries; Overall, the prevalence of thyroid disorders among patients with PCOS was 31%, the main thyroid disorder was autoimmune thyroiditis which represented 13.8% followed by subclinical hypothyroidism which found in 9.5% of all participants.
Conclusion: More than one third of the studied group had thyroid disorders. Autoimmune thyroiditis represented the main disorder.
References
March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544-551. doi:10.1093/humrep/dep399
Duran C, Basaran M, Kutlu O, Kucukaydin Z, Bakdik S, et al. Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome. Endocrine. 2015;49(2):464-469. doi:10.1007/s12020-014-0504-7
Moran LJ, Norman RJ, Teede HJ. Metabolic risk in PCOS: phenotype and adiposity impact. Trends Endocrinol Metab. 2015;26(3):136-143. doi:10.1016/j.tem.2014.12.003
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
Abalovich M, Mitelberg L, Allami C, Gutierrez S, Alcaraz G, et al. Subclinical hypothyroidism and thyroid autoimmunity in women with infertility. Gynecol Endocrinol. 2007;23(5):279-283.
Diaz A, Lipman Diaz EG. Hypothyroidism. Pediatr Rev. 2014;35(8):336-347. doi:10.1542/pir.35-8-336
Ganie MA, Marwaha RK, Aggarwal R, Singh S. High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study. Eur J Endocrinol. 2010;162(6):1117-1122.
Nanda SS, Dash S, Behera A, Mishra B. Thyroid profile in polycystic ovarian syndrome. J Evol Med Dent Sci. 2014;3(37):9594-600. doi:10.14260/jemds/2014/3242.
Najem FI, Elmehdawi RR, Swalem AM. Clinical and biochemical characteristics of polycystic ovary syndrome in Benghazi-Libya: a retrospective study. Libyan J Med. 2008;3:71-4. doi:10.3402/ljm.v3i2.4761.
Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005;90(7):4019-24. doi:10.1210/jc.2004-2225.
Rahmanpour H, Jamal L, Mousavinasab SN, Eslamloo RG, Azizi F. Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents. J Pediatr Endocrinol Metab. 2022 Feb 23;35(2):211-218.
Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, et al. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome. Eur J Endocrinol. 2006;155(6):859-65.
Li L, Yang D, Chen X, Chen Y, Feng S, Wang L. Clinical and metabolic features of polycystic ovary syndrome. Int J Gynaecol Obstet. 2007;97(2):129-34.
Hunter MH, Sterrett JJ. Polycystic ovary syndrome: It’s not just infertility. Am Fam Physician. 2000;62(5):1079-88.
Janssen OE, Mehlmauer N, Hahn S, Offner AH, Gärtner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol. 2004;150(3):363-9.
Arduc A, Aycicek Dogan B, Bilmez S, Imga Nasiroglu N, Tuna MM, Isik S, et al. High prevalence of Hashimoto’s thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role? Endocr Res. 2015;40(4):204-10.
Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK. Thyroid disorders in polycystic ovarian syndrome subjects: a tertiary hospital-based cross-sectional study from Eastern India. Indian J Endocrinol Metab. 2013;17(2):304-9.
Zeber-Lubecka N, Hennig EE. Genetic susceptibility to joint occurrence of polycystic ovary syndrome and Hashimoto’s thyroiditis: how far is our understanding? Front Immunol. 2021 Feb 26;12:606620. doi:10.3389/fimmu.2021.606620. PMID:33746952; PMCID:PMC7968419.
Raj D, Pooja F, Chhabria P, Kalpana F, Lohana S, Lal K, Shahid W, Naz S, Shahid S, Khalid D. Frequency of subclinical hypothyroidism in women with polycystic ovary syndrome. Cureus. 2021 Sep 4;13(9):e17722. doi:10.7759/cureus.17722. PMID:34659936; PMCID:PMC8490937.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Benghazi University Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright©2024University of Benghazi.
This open Access article is Distributed under a CC BY-NC-ND 4.0 license
Copyright
